MedPath

Effect of Dapoxitine, Paroxetine, Combination therapy of Dapoxetine/Tadalafil and Combination therapy of Paraoxytine/Tadalafil in premature ejaculatio

Phase 3
Completed
Conditions
Premature Ejaculation.
Premature ejaculation
F52.4
Registration Number
IRCT20190528043747N1
Lead Sponsor
Ardabil University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
120
Inclusion Criteria

Married men aged between 20 to 50 years
IELT less than 2 minutes
Having at least 1 sexual intercourse in a week

Exclusion Criteria

Having underlying disease including diabetes, hypertension, heart disease, thyroid disease, sexually transmitted disease, and psychiatric disease
Treated with any psychiatric medication
Erectile dysfunction

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.